Familial Hyperalphalipoproteinemia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:181428OMIM:143470
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Familial hyperalphalipoproteinemia (also known as familial high HDL cholesterol or elevated HDL syndrome) is a genetic condition characterized by persistently elevated levels of high-density lipoprotein cholesterol (HDL-C) in the blood, typically above the 90th percentile for age and sex. HDL cholesterol is commonly referred to as 'good cholesterol' because it plays a role in transporting cholesterol away from the arteries back to the liver for clearance. In most cases, familial hyperalphalipoproteinemia is considered a benign condition and may even be associated with a reduced risk of cardiovascular disease, though this protective effect is not universal and depends on the underlying genetic mechanism. The condition primarily affects lipid metabolism and the cardiovascular system. Most individuals with familial hyperalphalipoproteinemia are asymptomatic and are identified incidentally through routine lipid panel testing. The elevated HDL-C levels run in families and are caused by genetic variants affecting HDL metabolism, including mutations in genes such as CETP (cholesteryl ester transfer protein), LIPC (hepatic lipase), and others involved in HDL remodeling and clearance. Some forms, particularly those due to CETP deficiency, can result in very high HDL-C levels (above 100 mg/dL). Because familial hyperalphalipoproteinemia is generally considered a favorable lipid profile variant rather than a disease requiring treatment, no specific therapy is typically recommended. Management focuses on overall cardiovascular risk assessment and maintaining a healthy lifestyle. It is important to note that extremely elevated HDL-C levels caused by certain genetic variants may not always confer cardiovascular protection and should be evaluated in the context of the individual's complete metabolic and cardiovascular risk profile. Genetic counseling may be offered to affected families to clarify the inheritance pattern and underlying cause.

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Familial Hyperalphalipoproteinemia.

View clinical trials →

No actively recruiting trials found for Familial Hyperalphalipoproteinemia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Familial Hyperalphalipoproteinemia community →

No specialists are currently listed for Familial Hyperalphalipoproteinemia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Familial Hyperalphalipoproteinemia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Familial HyperalphalipoproteinemiaForum →

No community posts yet. Be the first to share your experience with Familial Hyperalphalipoproteinemia.

Start the conversation →

Latest news about Familial Hyperalphalipoproteinemia

No recent news articles for Familial Hyperalphalipoproteinemia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Familial Hyperalphalipoproteinemia

What is Familial Hyperalphalipoproteinemia?

Familial hyperalphalipoproteinemia (also known as familial high HDL cholesterol or elevated HDL syndrome) is a genetic condition characterized by persistently elevated levels of high-density lipoprotein cholesterol (HDL-C) in the blood, typically above the 90th percentile for age and sex. HDL cholesterol is commonly referred to as 'good cholesterol' because it plays a role in transporting cholesterol away from the arteries back to the liver for clearance. In most cases, familial hyperalphalipoproteinemia is considered a benign condition and may even be associated with a reduced risk of cardiov

How is Familial Hyperalphalipoproteinemia inherited?

Familial Hyperalphalipoproteinemia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.